Human oncostatin M antibodies

Interleukin-13 binding proteins

Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9

Anti-IL-6 antibodies, compositions, methods and uses

EGFR-binding molecules and immunoconjugates thereof

Anti-CD79B antibodies and immunoconjugates and methods of use

Methods of generating libraries and uses thereof

Therapeutic DLL4 binding proteins

Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists

Anti-ricin antibodies and uses thereof

RSV specific binding molecule

Modulators and methods of use

Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof

Cytotoxic benzodiazepine derivatives and methods of preparation

Antigenic GM-CSF peptides and antibodies to GM-CSF

Method for treating sarcopenia using antagonist antibodies against GDF-8

Method for preparing Fc containing polypeptides having improved properties

Optimized antibodies that target CD19

Humanized anti-TNF-α antibody and antigen-binding fragment (Fab) thereof and use of the same

Recombinant antibodies to the vascular endothelial growth factor (VEGF) which are obtained by means of mutagenesis of variable regions

Non-human animals expressing pH-sensitive immunoglobulin sequences

Polynucleotides encoding IL-31 monoclonal antibodies

Human monoclonal antibodies against Hendra and Nipah viruses

Method of improving patient survivability and quality of life by anti-IL-6 antibody administration

Anti-tissue factor antibodies and compositions

Antibody drug conjugates (ADC) that bind to 158P1D7 proteins

Anti-CD100 antibodies and methods of using the same

Antibodies that specifically bind alpha toxin and methods of use

Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1)

Methods and compositions comprising a combination of an anti-ErbB3 antibody and an anti-EGFR antibody

High affinity antibodies that neutralize enterotoxin B

Methods of treating sickle cell disease with anti-P-selectin antibodies

Antibodies against human angiopoietin 2

DNA encoding antibody molecules which bind IL-17A and IL-17F

Anti-kit antibodies

Antibody with specificity for GM-CSF (II)

Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof

Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof

Antibodies against human angiopoietin 2

Methods and systems for treating eclampsia or pre-eclampsia

Anti-N3pGlu amyloid beta peptide antibodies and uses thereof

Humanized anti-factor D antibodies and uses thereof

Therapeutic use of anti-CS1 antibodies

Complex in which anti-cotinine antibody is bound to conjugate of cotinine and binding substance, and use thereof

High affinity antibody antagonists of interleukin-13 receptor alpha 1

Human cytomegalovirus neutralising antibodies and use thereof

Anti-dengue virus antibodies and uses thereof

Anti-ASIC1 antibodies and uses thereof

Anti-kit antibodies

Human antibodies to GFRα3 and methods of use thereof

Anti-HER antibodies

Dual variable region antibody-like binding proteins having cross-over binding region orientation

High concentration antibody formulations

Humanized anti-IL-20 antibody and uses thereof

Humanized antibodies directed against complement protein C5

Neoantibodies for diagnosing tissue injury

Aldolases, nucleic acids encoding them and methods for making and using them

Anti-tace antibody molecules and their uses

Antibodies

Antibodies directed against influenza

Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use

Nucleic acids encoding neutralizing anti-CCL20 antibodies

CDIM binding proteins and uses thereof

Anti-PCSK9 antibodies with pH-dependent binding characteristics

Anti-TIM-3 antibody

Anti-SOD1 antibodies and uses thereof

Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

VNAR anti-cytokine domains

Human monoclonal antibodies specific for glypican-3 and use thereof

Human monoclonal antibody human CD134 (OX40) and methods of making and using same

Interleukin-10 fusion proteins

Nucleic acids encoding anti-NR10 antibodies

Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity

Antibodies that neutralize RSV, MPV and PVM and uses thereof

Antigen binding formats for use in therapeutic treatments or diagnostic assays

Anti-FGFR4 antibodies and methods of use

Expandable liquid volume in an LED bulb

A-beta binding polypeptides

Human antibodies and antibody-drug conjugates against CD74

METHODS OF TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS

Modified antibody compositions, methods of making and using thereof

Methods for making antibody molecules having specificity for human IL-6

Non-antagonistic EGFR-binding molecules and immunoconjugates thereof

Methods of enhancing antibody-based antiviral therapies by administering KIR2DL-binding antibodies

Antibodies specific for TGF-β and methods of treatment thereof

Antibody with specificity for GM-CSF (I)

Antibody to GDF8 and uses thereof

RSPO3 binding agents and uses thereof

Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases

Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same

Material and methods for treating or preventing HER-3 associated diseases

Antibodies against influenza virus and methods of use thereof

Dual variable region antibody-like binding proteins having cross-over binding region orientation

Antibody for 3′-isoLM1 and 3′,6′-iso-LD1 gangliosides

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof

Anti CD37 antibodies

Anti-IL-18 antibodies and their uses

Pharmaceutical compositions comprising IL-1B binding antibodies and fragments thereof

Anti-DR5 antibodies, polynucleotides and methods

antibodies

Stable and soluble antibodies inhibiting VEGF

Therapeutic peptides

ST2 antigen binding proteins

Nucleic acids encoding human glucagon receptor antibodies

Anti-human TROP-2 antibody having an antitumor activity in vivo

Anti-EGFR antibodies and uses thereof

Anti-PCSK9 antibodies, formulations, dosing, and methods of use

Anti-VEGF-C antibodies and methods using same

Antigen binding proteins that bind CCR2

Monoclonal antibody recognizing human papillomavirus (HPV) L2 protein and method for measuring HPV-neutralizing antibody titer using the same

Internalizing erbB2 antibodies

Antagonistic DR3 ligands

ST2L antibody antagonists

Binding members for interleukin-4 receptor alpha (IL-4Rα) - 173

Anti-TrkA antibodies, derivatives and uses thereof

Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly

Anti-LGR5 antibodies and immunoconjugates

Means and methods for producing high affinity antibodies

Anti-ErbB3 antibodies

Compositions relating to a mutant toxin and methods thereof

Humanized anti-EGFR antibody L4-H3 and coding gene thereof

Antagonistic DR3 ligands

Anti-IL-1β antibodies

Anti-NGF antibodies and their use

Chemokine receptor binding polypeptides

Antibody molecules having specificity for human OX40

Composition and method for the diagnosis and treatment of iron-related disorders

Single-domain antibodies that bind to HIV-1 Nef with high affinity

Antibodies for epidermal growth factor receptor 3 (HER3)

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tryptophanyl-tRNA synthetases

LOX and LOXL2 inhibitors and uses thereof

Antibodies that bind the glutamate ligand binding region of NOTCH3

Antigen binding proteins that bind PD-L1

Antigen binding proteins that bind delta-like 4 (DLL-4)

Antagonists of IL-6 to raise albumin and/or lower CRIP

Soluble heavy-chain only antibodies

Antibodies to tumor endothelial marker 8

Antibodies and immunoconjugates and uses therefor

Human monoclonal antibodies specific for CD22

Anti-VEGF antibodies

Anti-TLR4 antibodies and uses thereof

Bispecific antibodies to IL-23 and IL-17A/F

Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

Humanized anti-IL-20 antibody and uses thereof

Use of an anti-Tau pS422 antibody for the treatment of brain diseases

Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof

Methods of treating vascular disease using an IL-1beta Antibody

Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)

Pathogenic mycobacteria-derived mannose-capped lipoarabinomannan antigen binding proteins

Antagonists of IL-17A, IL-17F, and IL-23P19

Antibodies that bind epidermal growth factor receptor (EGFR)

Affinity peptides toward infliximab

Express humanization of antibodies

Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly

Compositions and methods for promoting liposomal and cellular adhesion

Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)

Anti-PCSK9 antibodies and use thereof

Modulators and methods of use

Alpha-4-beta-7 heterodimer specific antagonist antibody

HA binding agents

Agents for influenza neutralization

Single variable domain immunoglobulins that bind TGF-beta receptor II

Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same

Covalently-associated diabody complexes that possess charged coil domains and that are capable of enhanced binding to serum albumin

Anti-C5a receptor antibodies

Anti-erythropoietin antibodies

Antibodies against nerve growth factor (NGF) with enhanced in vivo stability

Monoclonal antibodies against frizzled

CD37-binding molecules and immunoconjugates thereof

Antibodies that bind factor P

Human antibodies to Fel d1 and methods of use thereof

Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

Binding proteins having tethered light chains

Dock-and-Lock (DNL) Complexes for delivery of interference RNA

Fibronectin based scaffold domain proteins that bind IL-23

Humanized anti-beta7 antagonists and uses therefor

Anti-ephrin-B2 antibody and compositions comprising it

Monoclonal antibodies that react with the capsule of

ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions

Anti-FGFR3 antibodies and methods using same

Human anti-KIR antibodies

Cells expressing anti-GD2 antibodies and methods related thereto

Antibodies against ROR1 and uses thereof

Antigen associated with the neovasculature of tumour metastases

Antibody targeting osteoclast-related protein Siglec-15

Antibodies to IL-6 and their uses

Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies

Anti-BAFF-anti-IL-17 bispecific antibodies

Binding proteins specific for insulin-like growth factors and uses thereof

Anti-CD100 neutralizing antibodies and methods of using the same

Peptides for generating an antibody selectively binding to a non-ATP-binding P2X7 receptor but not to an ATP-binding P2X7 receptor

Antibodies to NTB-A

Therapeutic antibodies against ROR-1 protein and methods for use of same

PCSK9 antagonists

Antibodies against a proliferating inducing ligand (APRIL) and methods of use thereof

Preparation of isolated agonist anti-EDAR monoclonal antibodies

FN14 binding proteins and uses thereof

Anti-CEACAM6 antibodies and uses thereof

Idiotypic antibodies and uses thereof

Anti-Notch1 antibodies

Anti-VEGF antibodies

Therapeutic factor VIII antibodies

Human antibodies to human angiopoietin-like protein 4

Antibodies selective for cells presenting ErbB2 at high density

Methods for treating conditions associated with MASP-2 dependent complement activation

Animal models and therapeutic molecules

Animal models and therapeutic molecules

Composition and method for diversification of target sequences

TEM-1 diagnostic antibodies

Anti-HLA-B*27 antibodies and uses thereof

Anti-cobra toxin antibody fragments and method of producing a VH library

Humanized antibodies to LIV-1 and use of same to treat cancer

Polynucleotides encoding for frizzled-binding agents and uses thereof

Anti-CXCR3 antibodies and methods of use thereof

Method of reducing the severity of stress hyperglycemia with human antibodies to the glucagon receptor

Antibodies against tissue factor pathway inhibitor

Humanized anti-CXCR5 antibodies, derivatives thereof and their use

Anti-huTNFR1 antibody and methods of use thereof for treatment

Monoclonal antibodies against Orthopoxviruses

Chimeric rabbit/human ROR1 antibodies

Non-human animals expressing pH-sensitive immunoglobulin sequences

Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same

Humanized anti-CXCR5 antibodies, derivatives thereof and their use

Fibronectin binding domains with reduced immunogenicity

Neutralising antibody molecules having specificity for human IL-17

Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding such

huTNFR1 selective antagonists

Polynucleotides encoding Toll-Like Receptor 3 antagonists

Human anti-CD27 antibodies, methods and uses

Humanized anti-CXCR5 antibodies, derivatives thereof and their use

Notch1 binding agents and methods of use thereof

Antibody molecules having specificity for human OX40

Anti-Axl antibodies and methods of use

Humanized monoclonal antibodies and methods of use

Antibodies

Humanized anti-CXCR5 antibodies, derivatives thereof and their use

Anti IL-36R antibodies

Monospecific and bispecific anti-IGF-1R and anti-ERBB3 antibodies

Dual specific binding proteins directed against IL-13 and IL-17

-specific antibodies and uses thereof

Interferon receptor 1 antibodies and their uses

Methods of treating systemic lupus erythematosus (SLE) using anti-CD48 antibodies

Human antibodies to toxins

Human antibodies that bind CD22 and uses thereof

Assay method for Alzheimer's disease

Anti-single-chain type IV collagen polypeptide antibody, pharmaceutical drug, diagnostic, preventive, or therapeutic drug for tumour containing the antibody

CX3CR1-binding polypeptides comprising immunoglobulin single variable domains

Antibodies to IL-6 to inhibit or treat inflammation

Anti-C5a antibodies

Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling

Antibodies to hepatocyte growth factor activator

Monoclonal antibodies against c-Met

Humaneered anti-factor B antibody

Anti-GD2 antibodies

Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)

Antibodies that bind myostatin, compositions and methods

Anti-tumor antigen antibodies and methods of use

DKK1 antibodies and methods of use

Fab-glycosylated antibodies

Humanized anti-CDCP1 antibodies

Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth

Anti-C-met antibody and methods of use thereof

Compositions and methods for treating IgE-mediated disorders

Compositions and methods for treating IgE-mediated disorders

Library-based methods and compositions for introducing molecular switch functionality into protein affinity reagents

Antibodies directed to αVβ6 and uses thereof

Antibodies for the treatment of -associated infection and disease

Anti-serum albumin binding variants

Antibodies directed against IL-17

Mice expressing a limited immunoglobulin light chain repertoire

Humanized universal light chain mice

Fibronectin binding domains with reduced immunogenicity

Antibodies

Human monoclonal antibody

Anti-ASIC1 antibodies and uses thereof

Human antibodies and uses therefor

Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment for use in therapy

Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-IG scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition

Nucleic acid encoding and method of producing anti-IL-17A/IL-17F cross-reactive antibodies

Antibody drug conjugates (ADC) that bind to 191P4D12 proteins

Carrier immunoglobulins and uses thereof

Monoclonal antibodies that specifically block biological activity of a tumor antigen

Monoclonal antibodies against HER2

Polynucleotides encoding an actriib antibody

Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof

Humanized antibodies targeting the EC1 domain of Cadherin-11 and related compositions and methods

Human tissue factor antibody and uses thereof

Methods of inducing or enhancing an immune response in a subject by administering agonistic GITR binding antibodies

Anti-LRP5 antibodies and methods of use

FGFR4 antibodies

Agonistic antibody to CD27

High affinity antibodies that neutralize enterotoxin B

Anti-CD19 antibody having ADCC function with improved glycosylation profile

Cancer therapy using CLDN6 target-directed antibodies in vivo

Anti-folate receptor alpha antibodies and uses thereof

Antagonists of IL-6 to treat cachexia, weakness, fatigue, and/or fever

Antagonists of IL-6 to raise albumin and/or lower CRP

Soluble human ST-2 antibodies and assays

PDGF receptor beta binding polypeptides